Risk of cardiovascular effects with azithromycin.
作者信息
Kumaresan Ramachandran, Palaian Subish, Thapa Santosh, Shankar Pathiyil Ravi
机构信息
Tutor, Department of Pharmacology / Hospital and Clinical Pharmacy, College of Medical Sciences , Bharatpur, Chitwan, Nepal .
Associate Professor, Department of Pharmacology/Hospital and Clinical Pharmacy, College of Medical Sciences , Bharatpur, Chitwan, Nepal .
出版信息
J Clin Diagn Res. 2015 Jan;9(1):FL01. doi: 10.7860/JCDR/2015/11092.5383. Epub 2015 Jan 1.
Abstract
摘要
相似文献
1
Risk of cardiovascular effects with azithromycin.阿奇霉素引起心血管效应的风险。
J Clin Diagn Res. 2015 Jan;9(1):FL01. doi: 10.7860/JCDR/2015/11092.5383. Epub 2015 Jan 1.
2
Azithromycin-induced proarrhythmia and cardiovascular death.阿奇霉素致心律失常和心血管死亡。
Ann Pharmacother. 2013 Nov;47(11):1547-51. doi: 10.1177/1060028013504905.
3
Azithromycin is not associated with QT prolongation in hospitalized patients with community-acquired pneumonia.阿奇霉素与社区获得性肺炎住院患者的QT间期延长无关。
Pharmacoepidemiol Drug Saf. 2015 Oct;24(10):1042-8. doi: 10.1002/pds.3842. Epub 2015 Aug 2.
4
A case-based approach to evaluating azithromycin use and cardiovascular risks.一种基于病例的方法来评估阿奇霉素的使用情况和心血管风险。
Consult Pharm. 2014 Jan;29(1):47-52. doi: 10.4140/TCP.n.2014.47.
5
Azithromycin and the risk of cardiovascular complications.阿奇霉素与心血管并发症风险
J Pharm Pract. 2014 Oct;27(5):496-500. doi: 10.1177/0897190013516503.
6
Use of microminipigs for unveiling unknown mechanisms of azithromycin-induced cardiovascular death.利用微小猪揭示阿奇霉素导致心血管死亡的未知机制。
J Pharmacol Sci. 2018 Nov;138(3):198-202. doi: 10.1016/j.jphs.2018.10.003. Epub 2018 Oct 17.
7
Is cardiovascular risk a concern when prescribing azithromycin?开具阿奇霉素处方时，心血管风险是否需要关注？
JAAPA. 2017 Jan;30(1):11-13. doi: 10.1097/01.JAA.0000511033.34198.95.
8
[LONG TERM TREATMENT WITH MACROLIDES IN CHRONIC LUNG DISEASES].[大环内酯类药物在慢性肺部疾病中的长期治疗]
Harefuah. 2016 Sep;155(9):567-571.
9
Risks of cardiac arrhythmia and mortality among patients using new-generation macrolides, fluoroquinolones, and β-lactam/β-lactamase inhibitors: a Taiwanese nationwide study.使用新一代大环内酯类、氟喹诺酮类和β-内酰胺/β-内酰胺酶抑制剂的患者发生心律失常和死亡的风险：一项台湾全国性研究。
Clin Infect Dis. 2015 Feb 15;60(4):566-77. doi: 10.1093/cid/ciu914. Epub 2014 Nov 18.
10
Azithromycin or erythromycin? Macrolides for non-cystic fibrosis bronchiectasis in adults: A systematic review and adjusted indirect treatment comparison.阿奇霉素或红霉素？大环内酯类药物治疗成人非囊性纤维化支气管扩张症：系统评价和调整后的间接治疗比较。
Chron Respir Dis. 2019 Jan-Dec;16:1479972318790269. doi: 10.1177/1479972318790269. Epub 2018 Aug 12.
引用本文的文献
1
Efficacy of COVID-19 treatments among geriatric patients: a systematic review.老年患者中新冠病毒疾病治疗方法的疗效：一项系统综述
Ther Adv Infect Dis. 2022 Jun 1;9:20499361221095666. doi: 10.1177/20499361221095666. eCollection 2022 Jan-Dec.
2
Adverse effects, pharmacological interactions, and cardiovascular drugs in COVID-19 treatment.在 COVID-19 治疗中药物的不良反应、药物相互作用和心血管药物。
Arch Cardiol Mex. 2021 Dec 20;91(Suplemento COVID):079-085. doi: 10.24875/ACM.20000234.
本文引用的文献
1
Azithromycin and the risk of cardiovascular death.阿奇霉素与心血管死亡风险。
N Engl J Med. 2012 May 17;366(20):1881-90. doi: 10.1056/NEJMoa1003833.
2
Azithromycin-induced QT prolongation in elderly patient.阿奇霉素致老年患者QT间期延长
Acta Biomed. 2006 Apr;77(1):30-2.
3
A case of QT-interval prolongation precipitated by azithromycin.一例由阿奇霉素引发的QT间期延长病例。
N Z Med J. 2003 Nov 7;116(1185):U666.
4
Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes.尽管大环内酯类抗生素导致的QT间期延长相似，但它们的促心律失常潜力却不同：快速复极3期可预防早期后除极和尖端扭转型室速。
J Pharmacol Exp Ther. 2002 Oct;303(1):218-25. doi: 10.1124/jpet.102.037911.
5
Azithromycin modulates neutrophil function and circulating inflammatory mediators in healthy human subjects.阿奇霉素可调节健康人体受试者的中性粒细胞功能和循环炎症介质。
Eur J Pharmacol. 2002 Aug 30;450(3):277-289. doi: 10.1016/s0014-2999(02)02042-3.
6
Blockade of human cardiac potassium channel human ether-a-go-go-related gene (HERG) by macrolide antibiotics.大环内酯类抗生素对人类心脏钾通道——人类醚-去极化相关基因（HERG）的阻断作用。
J Pharmacol Exp Ther. 2002 Jul;302(1):320-7. doi: 10.1124/jpet.302.1.320.
7
The newer macrolides: azithromycin and clarithromycin.新型大环内酯类药物：阿奇霉素和克拉霉素。
Infect Dis Clin North Am. 2000 Jun;14(2):449-62, x. doi: 10.1016/s0891-5520(05)70257-9.
8
Pharmacodynamics of macrolides, azalides, and streptogramins: effect on extracellular pathogens.大环内酯类、氮杂内酯类和链阳菌素类的药效学：对细胞外病原体的作用
Clin Infect Dis. 1998 Jul;27(1):28-32. doi: 10.1086/514619.
9
Chemistry and mode of action of macrolides.大环内酯类药物的化学性质及作用方式。
J Antimicrob Chemother. 1993 Mar;31 Suppl C:1-9. doi: 10.1093/jac/31.suppl_c.1.
Zotero 插件